Drugging the Epigenome: Overcoming Resistance to Targeted and Immunotherapies in Melanoma

This past decade has seen tremendous advances in understanding the molecular pathogenesis of melanoma and the development of novel effective therapies for melanoma. Targeted therapies and immunotherapies that extend survival of patients with advanced disease have been developed; however, the vast ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanly, Ailish, Gibson, Frederick, Nocco, Sarah, Rogers, Samantha, Wu, Muzhou, Alani, Rhoda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844701/
https://www.ncbi.nlm.nih.gov/pubmed/35199090
http://dx.doi.org/10.1016/j.xjidi.2021.100090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844701/
https://www.ncbi.nlm.nih.gov/pubmed/35199090
http://dx.doi.org/10.1016/j.xjidi.2021.100090

Ejemplares similares